Exact Mass: 452.2926

Repaglinide

C27H36N2O4 (452.2675)

Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to cells of the pancreas to stimulate insulin release. Repaglinide induces an early insulin response to meals decreasing postprandial blood glucose levels. It should only be taken with meals and meal-time doses should be skipped with any skipped meal. Approximately one month of therapy is required before a decrease in fasting blood glucose is seen. Meglitnides may have a neutral effect on weight or cause a slight increase in weight. The average weight gain caused by meglitinides appears to be lower than that caused by sulfonylureas and insulin and appears to occur only in those naive to oral antidiabetic agents. Due to their mechanism of action, meglitinides may cause hypoglycemia although the risk is thought to be lower than that of sulfonylureas since their action is dependent on the presence of glucose. In addition to reducing postprandial and fasting blood glucose, meglitnides have been shown to decrease glycosylated hemoglobin (HbA1c) levels, which are reflective of the last 8-10 weeks of glucose control. Meglitinides appear to be more effective at lowering postprandial blood glucose than metformin, sulfonylureas and thiazolidinediones. Repaglinide is extensively metabolized in the liver and excreted in bile. Repaglinide metabolites do not possess appreciable hypoglycemic activity. Approximately 90\\% of a single orally administered dose is eliminated in feces and 8\\% in urine. C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents

7-O-Dmethylcephaeline

C27H36N2O4 (452.2675)

Tyromycic acid

C30H44O3 (452.329)

Tyromycic acid is found in mushrooms. Tyromycic acid is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Tyromycic acid is found in mushrooms.

(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide

C28H36O5 (452.2563)

(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is found in fruits. (14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is a constituent of Physalis peruviana (Cape gooseberry) Constituent of Physalis peruviana (Cape gooseberry). (14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide is found in fruits.

3-Oxo-12,18-ursadien-28-oic acid

C30H44O3 (452.329)

3-Oxo-12,18-ursadien-28-oic acid is found in pomes. 3-Oxo-12,18-ursadien-28-oic acid is a constituent Pyrus communis (pear). Constituent Pyrus communis (pear). 3-Oxo-18-dehydroursolic acid is found in pomes.

1-nonadecanoyl-glycero-3-phosphate

C22H45O7P (452.2903)

1-nonadecanoyl-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-nonadecanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule

LysoPA(19:0/0:0)

C22H45O7P (452.2903)

LysoPA(19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(19:0/0:0), in particular, consists of one chain of nonadecylic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

LysoPA(i-19:0/0:0)

C22H45O7P (452.2903)

LysoPA(i-19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-19:0/0:0), in particular, consists of one chain of isononadecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

24,24-Difluoro-1alpha,25-dihydroxyvitamin D3

C27H42F2O3 (452.3102)

Parenabol

C30H44O3 (452.329)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

Tribendimidine

C28H32N6 (452.2688)

Tribendimidine is an orally active, broad-spectrum anthelmintic agent, with particularly high activity against A. lumbricoides and N. americanus. Tribendimidine is also an L-type nicotinic acetylcholine receptor (nAChR) agonist[1][2][3].

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

C31H36N2O (452.2827)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.2774)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.2774)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.2774)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.2774)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.2774)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.2774)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.2774)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Strychnine

C21H22N2O2.1/2H2SO4 (452.292)

Tyromycic acid E

C30H44O3 (452.329)

Withametelin M

C28H36O5 (452.2563)

20,21alpha-Dihydroxy-22-oxo-21-desoxotingenone

C28H36O5 (452.2563)

Melliferone

C30H44O3 (452.329)

Chabrolobenzoquinone F

C29H40O4 (452.2926)

10-O-Demethylcephaeline

C27H36N2O4 (452.2675)

Kulactone

C30H44O3 (452.329)

16,21-Epoxylanosta-7,24-diene-3,21-dione is a natural product found in Melia with data available.

20-Oxo-20,21-seco-tingen-21-oic acid

C28H36O5 (452.2563)

Supinenolone D

C30H44O3 (452.329)

Halisulfate 7

C25H40O5S (452.2596)

3-Oxo-11,13(18)-oleandien-28-oic acid

C30H44O3 (452.329)

Lucialdehyde B

C30H44O3 (452.329)

A tetracyclic triterpenoid that is lanosta-8,24-dien-26-al substituted by oxo groups at positions 3 and 7. Isolated from Ganoderma lucidum and Ganoderma pfeifferi, it exhibits antiviral and cytotoxic activities.

Withametelin L

C28H36O5 (452.2563)

NSC349983

C28H36O5 (452.2563)

Antiostatin B3

C26H36N4O3 (452.2787)

Nimocinol

C28H36O5 (452.2563)

Stellettin J

C30H44O3 (452.329)

Antiostatin B4

C26H36N4O3 (452.2787)

15alpha,22beta-Dihydroxytingenone

C28H36O5 (452.2563)

6alpha-O-Acetyl-7-deacetylnimocinol

C28H36O5 (452.2563)

Briarellin P

C25H40O7 (452.2774)

Sch 599473

C25H40O5S (452.2596)

Celastranhydride

C28H36O5 (452.2563)

caribaeorane

C27H36N2O4 (452.2675)

Blazeispirol Y

C28H36O5 (452.2563)

Withacoagulin

C28H36O5 (452.2563)

Trichilenone acetate

C28H36O5 (452.2563)

Tyromycic acid

C30H44O3 (452.329)

20,22beta-dihydroxytingenone

C28H36O5 (452.2563)

7-O-Demethylisocephaeline

C27H36N2O4 (452.2675)

A pyridoisoquinoline consisting of (1beta)-emetan substituted by hydroxy groups at positions 6 and 7 and methoxy groups at positions 10 and 11. It is isolated from Psychotria klugii and exhibits antileishmanial activity.

9-O-Demethylcephaeline

C27H36N2O4 (452.2675)

(E)-5-hydroxy-N-[3-[5-[3-[[(E)-5-hydroxy-3-methylpent-2-enoyl]amino]propyl]-3,6-dioxopiperazin-2-yl]propyl]-3-methylpent-2-enamide

C22H36N4O6 (452.2635)

2-Picenecarboxylic acid

C28H36O5 (452.2563)

7-hydroxy-6-oxopristimerol

C28H36O5 (452.2563)

Laserpitinol

C25H40O7 (452.2774)

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

C25H40O7 (452.2774)

(20R,22R)-21,24-epoxy-5beta-hydroxy-1-oxowitha-2,9(11),25(27)-trienolide|withametelinol-A

C28H36O5 (452.2563)

Benzoylramanone

C28H36O5 (452.2563)

10-hidroxy 4,17-dihydro 17 beta-tchibangensine

C29H32N4O (452.2576)

2alpha,3beta-dihydroxy-28-norurs-12,17,19(20),21(22)-tetraen-23-oic acid|2alpha,3beta-dihydroxy-28-norursa-12,17,19(20),21-tetraen-23-oic acid

C29H40O4 (452.2926)

SCHEMBL370562

C26H44O6 (452.3138)

18-dihydrocinnamoyloxy-labda-7,13E-dien-15-oic acid

C29H40O4 (452.2926)

C28H36O5

C28H36O5 (452.2563)

19-(p-hydroxyhydrocinnamoyloxy)-ent-kauran-17-al|19--ent-kauran-17-al

C29H40O4 (452.2926)

proceranone

C28H36O5 (452.2563)

grindelic acid 15-O-arabinoside

C25H40O7 (452.2774)

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

C25H40O7 (452.2774)

Ecdysteron

C25H40O7 (452.2774)

Trihomononactic acid cyclic dimer

C26H44O6 (452.3138)

shimalactone B

C29H40O4 (452.2926)

C29H40O4

C29H40O4 (452.2926)

C25H40O5S

C25H40O5S (452.2596)

Withanolide B

C29H40O4 (452.2926)

withametelin B

C28H36O5 (452.2563)

acnistin B

C28H36O5 (452.2563)

C25H40O7

C25H40O7 (452.2774)

Withametelin F|withmetelin F

C28H36O5 (452.2563)

Withanolid O

C28H36O5 (452.2563)

13-O-alpha-rhamnopyranosyl-(+)-3beta-hydroxymanool

C26H44O6 (452.3138)

1,10-seco-withametelin B

C28H36O5 (452.2563)

(4S,5S,7R,10S)-Eudesm-11-en-4-ol 2-O-((2S) 2-methylbutyryl)-beta-D-fucopyranoside|(4S,5S,7R,10S)-Eudesm-11-en-4-ol 2-O-<(2S) 2-methylbutyryl>-beta-D-fucopyranoside

C26H44O6 (452.3138)

Delta16-withanolide

C28H36O5 (452.2563)

27-Hydroxy-3-oxo-witha-1,4,24-trienolide

C29H40O4 (452.2926)

Excelsine

C29H40O4 (452.2926)

antidesmanin E|antidesmanin F|erythro-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol|threo-4-(2-(2-methoxy-4-((E)-3,3-dimethylpenta-1,4-dienyl)phenoxy)-1-hydroxy-3,3-dimethylpent-4-enyl)-2-methoxyphenol

C28H36O5 (452.2563)

(20R,22R)-17beta-hydroxy-1,12-dioxowitha-2,5,24-trien-26,22-olide|jaborosalactone 44

C28H36O5 (452.2563)

(7S,11S,12S)-1-methoxycystoketal

C29H40O4 (452.2926)

pseudoferic acid A

C29H40O4 (452.2926)

dothideomycetone B

C25H40O7 (452.2774)

5,6-acetonylgrayanotoxin-I

C25H40O7 (452.2774)

(2S,3S,6R,7R,10R,11R,14S)-zonaquinone acetate

C29H40O4 (452.2926)

O-3-isovaleroyl alpha-bisabolol beta-D-fucopyranoside

C26H44O6 (452.3138)

eucalyptal D

C28H36O5 (452.2563)

16-en-27-deoxywithaferin A

C28H36O5 (452.2563)

spiralisone B

C28H36O5 (452.2563)

24,25,26,27-tetra-norapotirucalla-(apoeupha)-6alpha-acetoxy-7alpha-hydroxy-1,14,20,22-tetraen-21,23-epoxy-3-one|6alpha-O-acetyl-7-deacetylnimocinol

C28H36O5 (452.2563)

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

C25H40O7 (452.2774)

3alpha,7alpha,12alpha,23-Tetrahydroxy-cholansaeure-ethylester

C26H44O6 (452.3138)

(22R)-4beta,27-dihydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4,27-dihydroxy-1-oxo-witha-2,5,16,24-tetraenolide

C28H36O5 (452.2563)

(20R,22R)-14,20-Dihydroxy-1-oxowitha-2,5,16,22-tetraenolide

C28H36O5 (452.2563)

withanolide U

C28H36O5 (452.2563)

amphidinolide T2

C26H44O6 (452.3138)

Vepinin

C28H36O5 (452.2563)

norselic acid A

C29H40O4 (452.2926)

8|A-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate

C29H40O4 (452.2926)

L-MeIle-L-Acm-L-Glu

C22H36N4O6 (452.2635)

3,22beta-dihydroxy-24,29-dinor-1(10),3,5-friedelatriene-2,7,21-trione

C28H36O5 (452.2563)

salaquinone B

C28H36O5 (452.2563)

DTXSID20855115

C26H44O6 (452.3138)

Natalic acid

C29H40O4 (452.2926)

coagulin F

C28H36O5 (452.2563)

C26H44O6

C26H44O6 (452.3138)

lettowinone|methyl [3-(3,7-dimethylocta.2,6-dienyl)-6-methyl-5-(3-methylbut-2-enyl)-1,4-dioxo-1,5,8,8a-tetrahydro-4H-naphthalen-4a-yl]acetate

C29H40O4 (452.2926)

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

C25H40O7 (452.2774)

2.3-dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-oic acid-(29)|2.3-Dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-saeure-(29)|Dihydrocelastrol

C29H40O4 (452.2926)

(22R,Z)-16beta,27-dihydroxy-1-oxo-witha-2,5,17(20),24-tetraenolide

C28H36O5 (452.2563)

3,7,9-trihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O5 (452.2563)

13S-labda-8(17),14-diene-13-(cis-hydroxycinnamoxy)-19-ol

C29H40O4 (452.2926)

(20R,22R)-14,20-Dihydroxy-1-oxowitha-2,4,6,24-tetraenolide|14alpha,20alphaF-dihydroxy-1-oxo-22R-witha-2,4,6,24-tetraenolide

C28H36O5 (452.2563)

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

C25H40O7 (452.2774)

16-en-27-deoxywithaferin A|27-deoxy-Delta(16)-withaferin A|5beta,6beta-epoxy-4beta-hydroxy-1-oxo-witha-2,16,24-trienolide

C28H36O5 (452.2563)

calotropone

C28H36O5 (452.2563)

17-hydroxy-19-(p-hydroxyhydrocinnamoyloxy)-iso-kaurene|17-hydroxy-19--iso-kaurene

C29H40O4 (452.2926)

Tomentin

C25H40O7 (452.2774)

sulfircin

C25H40O5S (452.2596)

Dresigenin B

C26H44O6 (452.3138)

6-oxo-20-hydroxy-20-epi-tingenol

C28H36O5 (452.2563)

Triptohypol C

C29H40O4 (452.2926)

Triptohypol C is a pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. It has a role as a plant metabolite and an apoptosis inducer. It is a pentacyclic triterpenoid, a monocarboxylic acid and a member of benzenediols. Dihydrocelastrol is a natural product found in Tripterygium hypoglaucum and Tripterygium wilfordii with data available. A pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. Triptohypol C, a Tripterin (HY-13067) derivative, is a potent Nur77-targeting anti-inflammatory agent with an Kd value of 0.87 μM. Triptohypol C inhibits inflammatory response by promoting the interactions of Nur77 with TRAF2 and p62/SQSTM1[1].

Glabralide C

C29H40O4 (452.2926)

Repaglinide

C27H36N2O4 (452.2675)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 2189 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3349

C28H36O5_2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydro-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)

C28H36O5 (452.2563)

(2R,4aS,6aR,6aS,14aS,14bR)-10,11-dihydroxy-2,4a,6a,6a,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

C28H36O5 (452.2563)

18,19-dihydrousambarine

C30H36N4 (452.294)

Dihydrocelastrol

C29H40O4 (452.2926)

Ala His Ile Ile

C21H36N6O5 (452.2747)

Ala His Ile Leu

C21H36N6O5 (452.2747)

Ala His Leu Ile

C21H36N6O5 (452.2747)

Ala His Leu Leu

C21H36N6O5 (452.2747)

Ala Ile His Ile

C21H36N6O5 (452.2747)

Ala Ile His Leu

C21H36N6O5 (452.2747)

Ala Ile Ile His

C21H36N6O5 (452.2747)

Ala Ile Leu His

C21H36N6O5 (452.2747)

Ala Leu His Ile

C21H36N6O5 (452.2747)

Ala Leu His Leu

C21H36N6O5 (452.2747)

Ala Leu Ile His

C21H36N6O5 (452.2747)

Ala Leu Leu His

C21H36N6O5 (452.2747)

His Ala Ile Ile

C21H36N6O5 (452.2747)

His Ala Ile Leu

C21H36N6O5 (452.2747)

His Ala Leu Ile

C21H36N6O5 (452.2747)

His Ala Leu Leu

C21H36N6O5 (452.2747)

His Ile Ala Ile

C21H36N6O5 (452.2747)

His Ile Ala Leu

C21H36N6O5 (452.2747)

His Ile Ile Ala

C21H36N6O5 (452.2747)

His Ile Leu Ala

C21H36N6O5 (452.2747)

His Leu Ala Ile

C21H36N6O5 (452.2747)

His Leu Ala Leu

C21H36N6O5 (452.2747)

His Leu Ile Ala

C21H36N6O5 (452.2747)

His Leu Leu Ala

C21H36N6O5 (452.2747)

His Val Val Val

C21H36N6O5 (452.2747)

Ile Ala His Ile

C21H36N6O5 (452.2747)

Ile Ala His Leu

C21H36N6O5 (452.2747)

Ile Ala Ile His

C21H36N6O5 (452.2747)

Ile Ala Leu His

C21H36N6O5 (452.2747)

Ile His Ala Ile

C21H36N6O5 (452.2747)

Ile His Ala Leu

C21H36N6O5 (452.2747)

Ile His Ile Ala

C21H36N6O5 (452.2747)

Ile His Leu Ala

C21H36N6O5 (452.2747)

Ile Ile Ala His

C21H36N6O5 (452.2747)

Ile Ile His Ala

C21H36N6O5 (452.2747)

Ile Leu Ala His

C21H36N6O5 (452.2747)

Ile Leu His Ala

C21H36N6O5 (452.2747)

Leu Ala His Ile

C21H36N6O5 (452.2747)

Leu Ala His Leu

C21H36N6O5 (452.2747)

Leu Ala Ile His

C21H36N6O5 (452.2747)

Leu Ala Leu His

C21H36N6O5 (452.2747)

Leu His Ala Ile

C21H36N6O5 (452.2747)

Leu His Ala Leu

C21H36N6O5 (452.2747)

Leu His Ile Ala

C21H36N6O5 (452.2747)

Leu His Leu Ala

C21H36N6O5 (452.2747)

Leu Ile Ala His

C21H36N6O5 (452.2747)

Leu Ile His Ala

C21H36N6O5 (452.2747)

Leu Leu Ala His

C21H36N6O5 (452.2747)

Leu Leu His Ala

C21H36N6O5 (452.2747)

Val His Val Val

C21H36N6O5 (452.2747)

Val Val His Val

C21H36N6O5 (452.2747)

Val Val Val His

C21H36N6O5 (452.2747)

4,4-difluoro-1α,25-dihydroxyvitamin D3 / 4,4-difluoro-1α,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

(5Z,7E)-(1S,3S)-4,4-difluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H42F2O3 (452.3102)

23,23-difluoro-1α,25-dihydroxyvitamin D3 / 23,23-difluoro-1α,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

24,24-difluoro-1α,25-dihydroxyvitamin D3 / 24,24-difluoro-1α,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

PA(19:0/0:0)

C22H45O7P (452.2903)

PA(O-20:0/0:0)

C23H49O6P (452.3267)

(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide

C28H36O5 (452.2563)

Sarcoehrendin I

C25H40O7 (452.2774)

LPA 19:0

C22H45O7P (452.2903)

LPA O-20:0

C23H49O6P (452.3267)

ST 28:7;O5

C28H36O5 (452.2563)

4,4-difluoro-1alpha,25-dihydroxyvitamin D3

C27H42O3F2 (452.3102)

23,23-difluoro-1alpha,25-dihydroxyvitamin D3

C27H42O3F2 (452.3102)

24,24-difluoro-1alpha,25-dihydroxyvitamin D3

C27H42O3F2 (452.3102)

POLY(LAURYL METHACRYLATE-CO-ETHYLENE GLYCOL DIMETHACRYLATE)

C26H44O6 (452.3138)

8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnaMate

C29H40O4 (452.2926)

1-Propanol, 2-methoxy-3-[(9Z)-9-octadecenyloxy]-, dihydrogen phosphorothioate, (2R)

C22H45O5PS (452.2725)

1-hexadecyl-3-methylimidazolium hexafluorophosphate

C20H39F6N2P (452.2755)

N-(2-ethoxyphenyl)-N-(4-isododecylphenyl)oxamide

C28H40N2O3 (452.3039)

Etripamil

C27H36N2O4 (452.2675)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

Propargyl-PEG9-OH

C21H40O10 (452.2621)

R 5011 (dopant)

C32H36O2 (452.2715)

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

C31H36N2O (452.2827)

YM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A[1][2].

Paraminabeolide F

C28H36O5 (452.2563)

A withanolide that is 18,22:23,26-diepoxyergosta-1,4-diene substituted by oxo groups at positions 3, 18 and 26. It has been isolated from a Formosan soft coral Paraminabea acronocephala.

Butropium

C28H38NO4+ (452.2801)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

2-Ethoxy-4-[2-[[3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid

C27H36N2O4 (452.2675)

EleutherazineB

C22H36N4O6 (452.2635)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines

Tacrine(8)-4-aminoquinoline

C30H36N4 (452.294)

23,23-difluoro-1alpha,25-dihydroxyvitamin D3/23,23-difluoro-1alpha,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)

C21H43NO7P- (452.2777)

[(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-bis(azaniumyl)-3-[[(2S,3R)-3-azaniumyl-6-(azaniumylmethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-3,5-dihydroxy-5-methyloxan-4-yl]-methylazanium

C19H42N5O7+5 (452.3084)

(5Z)-5-[(2E)-2-[1-(5,5-difluoro-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C27H42F2O3 (452.3102)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.2774)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.2774)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.2774)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.2774)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.2774)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.2774)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.2774)

[3-carboxy-2-[(10E,12E,14E)-9-hydroxy-16-oxooctadeca-10,12,14-trienoyl]oxypropyl]-trimethylazanium

C25H42NO6+ (452.3012)

[3-carboxy-2-[(10E,12E,14E)-16-hydroxy-9-oxooctadeca-10,12,14-trienoyl]oxypropyl]-trimethylazanium

C25H42NO6+ (452.3012)

8alpha-Hydroxylabda-13(16),14-dien-19-yl-cis-4-hydroxycinnamate

C29H40O4 (452.2926)

A natural product found in Metasequoia glyptostroboides.

Ala-Leu-Leu-His

C21H36N6O5 (452.2747)

A tetrapeptide composed of L-alanine, two L-leucine units, and an L-histidine joined in sequence.

epiandrosterone 3-beta-D-glucoside

C25H40O7 (452.2774)

A sterol 3-beta-D-glucoside that has epiandrosterone as the sterol component.

1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(2-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea

C26H36N4OS (452.261)

1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(3-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea

C26H36N4OS (452.261)

1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(4-methylphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea

C26H36N4OS (452.261)

[(E)-2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1S,6R)-1,2,6-trimethylcyclohex-2-en-1-yl]oct-5-enyl] hydrogen sulfate

C25H40O5S (452.2596)

4-(dimethylamino)-N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

4-(dimethylamino)-N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

4-(dimethylamino)-N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

4-(dimethylamino)-N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

Vanoxerine(2+)

C28H34F2N2O+2 (452.2639)

2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)

2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-tetradec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C22H47NO6P+ (452.3141)

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-tetradec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C22H47NO6P+ (452.3141)

[(2S)-2-hydroxy-3-[(3R,7R,11R)-3,7,11,15-tetramethylhexadecoxy]propyl] dihydrogen phosphate

C23H49O6P (452.3267)

[2-(Heptanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[2-(Hexanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[2-(Butanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[3-Hydroxy-2-(propanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

(2-Acetamido-3-hydroxytetradecyl) 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[3-Hydroxy-2-(pentanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[3-Hydroxy-2-(octanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)

2-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C22H47NO6P+ (452.3141)

1-nonadecanoyl-glycero-3-phosphate

C22H45O7P (452.2903)

lysophosphatidylethanolamine zwitterion 16:0

C21H43NO7P (452.2777)

A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 16 carbons and 0 double bonds.

BisMeLPA(17:0)

C22H45O7P (452.2903)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Trp 17:2(9Z,12Z)

C28H40N2O3 (452.3039)

NA-Orn 20:2

C25H44N2O5 (452.325)

FAHFA 10:2/O-19:6

C29H40O4 (452.2926)

FAHFA 10:3/O-19:5

C29H40O4 (452.2926)

FAHFA 11:2/O-18:6

C29H40O4 (452.2926)

FAHFA 11:3/O-18:5

C29H40O4 (452.2926)

FAHFA 12:3/O-17:5

C29H40O4 (452.2926)

FAHFA 12:4/O-17:4

C29H40O4 (452.2926)

FAHFA 13:3/O-16:5

C29H40O4 (452.2926)

FAHFA 13:4/O-16:4

C29H40O4 (452.2926)

FAHFA 14:3/O-15:5

C29H40O4 (452.2926)

FAHFA 14:4/O-15:4

C29H40O4 (452.2926)

FAHFA 15:4/O-14:4

C29H40O4 (452.2926)

FAHFA 15:5/O-14:3

C29H40O4 (452.2926)

FAHFA 16:4/O-13:4

C29H40O4 (452.2926)

FAHFA 16:5/O-13:3

C29H40O4 (452.2926)

FAHFA 17:4/O-12:4

C29H40O4 (452.2926)

FAHFA 17:5/O-12:3

C29H40O4 (452.2926)

FAHFA 18:5/O-11:3

C29H40O4 (452.2926)

FAHFA 18:6/O-11:2

C29H40O4 (452.2926)

FAHFA 19:5/O-10:3

C29H40O4 (452.2926)

FAHFA 19:6/O-10:2

C29H40O4 (452.2926)

FAHFA 20:5/O-9:3

C29H40O4 (452.2926)

FAHFA 20:6/O-9:2

C29H40O4 (452.2926)

FAHFA 21:6/O-8:2

C29H40O4 (452.2926)

FAHFA 21:7/O-8:1

C29H40O4 (452.2926)

FAHFA 29:8;O

C29H40O4 (452.2926)

FAHFA 8:1/O-21:7

C29H40O4 (452.2926)

FAHFA 8:2/O-21:6

C29H40O4 (452.2926)

FAHFA 9:2/O-20:6

C29H40O4 (452.2926)

FAHFA 9:3/O-20:5

C29H40O4 (452.2926)

LPEth 17:0

C22H45O7P (452.2903)

LPM 18:0

C22H45O7P (452.2903)

SM 16:0;O2

C21H45N2O6P (452.3015)

SM 8:0;O2/8:0

C21H45N2O6P (452.3015)

ST 19:0;O;GlcA

C25H40O7 (452.2774)

ST 19:1;O2;Hex

C25H40O7 (452.2774)

ST 20:0;O;Hex

C26H44O6 (452.3138)

ST 25:2;O2;S

C25H40O5S (452.2596)

ST 26:1;O;S

C26H44O4S (452.296)

ST 25:2;O7

C25H40O7 (452.2774)

ST 26:1;O6

C26H44O6 (452.3138)

2-ethoxy-4-({[(1s)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]-c-hydroxycarbonimidoyl}methyl)benzoic acid

C27H36N2O4 (452.2675)

(1r,2r,8s,10r,11r,15r,16s)-15-(furan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-10-yl acetate

C28H36O5 (452.2563)

2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-(undecan-2-yl)-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C26H44O6 (452.3138)

(1s,2s,4s,5s,8r,9s,10z,12r)-12-hydroxy-8-isopropyl-1,5,11-trimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-6,10,13-trien-2-yl (2e)-3-(1-methylimidazol-4-yl)prop-2-enoate

C27H36N2O4 (452.2675)

(1r,5r,8r)-8-[(1r,3as,3bs,5as,9ar,11as)-5a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

(1s,2r,4r,6r,7s,10r,11r,16r,18r)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate

C28H36O5 (452.2563)

(2e)-5-[(1s,4ar,5r,8ar)-2,5,8a-trimethyl-5-{[(3-phenylpropanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C29H40O4 (452.2926)

(1r,3as,9as,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid

C29H40O4 (452.2926)

6-(1-{3a-hydroxy-9a,11a-dimethyl-9-oxo-3h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

(2-{2-[(1s,2r,4as,8ar)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl)oxysulfonic acid

C25H40O5S (452.2596)

1-(furan-2-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate

C28H36O5 (452.2563)

4,5-dihydroxy-6-methyl-2-({1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl}oxy)oxan-3-yl 2-methylbutanoate

C26H44O6 (452.3138)

(2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

C28H36O5 (452.2563)

(1r,3as,3br,9ar,9bs,11as)-1-[(1r)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,9bh,10h-cyclopenta[a]phenanthrene-9,11-dione

C28H36O5 (452.2563)

[5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

1-({3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}methyl)-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C27H36N2O4 (452.2675)

6-(1-{6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

(6e,10e)-6,10-dimethyl-12-(4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl acetate

C29H40O4 (452.2926)

20-methyl-7,17,21,31-tetraazaoctacyclo[19.10.1.0³,¹⁹.0⁵,¹⁷.0⁶,¹⁴.0⁸,¹³.0²²,²⁷.0²⁸,³²]dotriaconta-6(14),8,10,12,18,22,24,26-octaen-11-ol

C29H32N4O (452.2576)

(1s,2r,7s,9r,11s,12s,15r,16s)-2,16-dimethyl-15-[(1s,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one

C28H36O5 (452.2563)

2,6,11,15-tetramethyl-5,14-dipropyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

C26H44O6 (452.3138)

(6r)-6-[(1r,6s,9as,11ar)-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O4 (452.2926)

4-[(1r,2r)-2-[4-(3,3-dimethylpenta-1,4-dien-1-yl)-2-methoxyphenoxy]-1-hydroxy-3,3-dimethylpent-4-en-1-yl]-2-methoxyphenol

C28H36O5 (452.2563)

3,10,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,10,12,12a,13,14-hexahydro-7h-picene-2,9-dione

C28H36O5 (452.2563)

(1s,3br,4r,5ar,9ar,9br,11s,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl acetate

C28H36O5 (452.2563)

17β-hydroxy-14α,20α-epoxy-1-oxo-(22r)-witha-3,5,24-trienolide

C28H36O5 (452.2563)

{"Ingredient_id": "HBIN001994","Ingredient_name": "17\u03b2-hydroxy-14\u03b1,20\u03b1-epoxy-1-oxo-(22r)-witha-3,5,24-trienolide","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "CC1=C(C(=O)OC(C1)C2(C3(CCC4(C3(CCC5C4CC=C6C5(C(=O)CC=C6)C)C)O2)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10091","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2α,3β-dihydroxy-28-norurs-12,17,19(20),21-te-traen-23-oiccid

C29H40O4 (452.2926)

{"Ingredient_id": "HBIN005224","Ingredient_name": "2\u03b1,3\u03b2-dihydroxy-28-norurs-12,17,19(20),21-te-traen-23-oiccid","Alias": "NA","Ingredient_formula": "C29H40O4","Ingredient_Smile": "CC1=C(C2=C(CCC3(C2=CCC4C3(CCC5C4(CC(C(C5(C)C(=O)O)O)O)C)C)C)C=C1)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15125","TCMID_id": "6054","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5β,6β-epoxy-4β-hydroxy-1-oxowitha-2,14,24-trienolide

C28H36O5 (452.2563)

{"Ingredient_id": "HBIN011454","Ingredient_name": "5\u03b2,6\u03b2-epoxy-4\u03b2-hydroxy-1-oxowitha-2,14,24-trienolide","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "CC12CC=C3C(C1CCC2C4COC5(CC4OC(=O)C5=C)C)CCC6(C3(C(=O)C=CC6)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7127","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5β,6β-epoxy-4β-hydroxy-1-oxo-witha-2,16,24-trienolide

C28H36O5 (452.2563)

{"Ingredient_id": "HBIN011455","Ingredient_name": "5\u03b2,6\u03b2-epoxy-4\u03b2-hydroxy-1-oxo-witha-2,16,24-trienolide","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7128","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

6α-o-acetyl-7-deacetylnimocinol

C28H36O5 (452.2563)

{"Ingredient_id": "HBIN012215","Ingredient_name": "6\u03b1-o-acetyl-7-deacetylnimocinol","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "364","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

8α-hydroxyabda-13(16),14-dien-19-yl-(z)-4-hy-droxycinnamate

C29H40O4 (452.2926)

{"Ingredient_id": "HBIN013630","Ingredient_name": "8\u03b1-hydroxyabda-13(16),14-dien-19-yl-(z)-4-hy-droxycinnamate","Alias": "NA","Ingredient_formula": "C29H40O4","Ingredient_Smile": "CC1(CCCC2(C1CCC(C2CCC(=C)C=C)(C)O)C)COC(=O)C=CC3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10299","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

benzoylramanone

C28H36O5 (452.2563)

{"Ingredient_id": "HBIN017830","Ingredient_name": "benzoylramanone","Alias": "NA","Ingredient_formula": "C28H36O5","Ingredient_Smile": "CC(=O)C1CCC2(C1(C(CC3C2CC=C4C3(CCC(C4)O)C)OC(=O)C5=CC=CC=C5)C)O","Ingredient_weight": "452.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2268","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101974123","DrugBank_id": "NA"}

(1r,3ar,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

12-hydroxy-8-isopropyl-1,5,11-trimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-5,10,13-trien-2-yl 3-(1-methylimidazol-4-yl)prop-2-enoate

C27H36N2O4 (452.2675)

(2-{2-[(1s,2s,4ar)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl)oxysulfonic acid

C25H40O5S (452.2596)

4,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,8,13,14,14b-octahydropicene-3,6-dione

C28H36O5 (452.2563)

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)

(1r,5r,8r)-8-[(1r,3as,3bs,5r,9ar,9bs,11as)-5-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

2-{[1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 2-methylbutanoate

C26H44O6 (452.3138)

(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-3-(3h-imidazol-4-yl)propanoic acid

C21H36N6O5 (452.2747)

(1r,3br,4s,5r,5ar,9ar,9br,11as)-1-(furan-2-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate

C28H36O5 (452.2563)

methyl 2-[(4as,5r,8as)-2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-5-(3-methylbut-2-en-1-yl)-1,4-dioxo-8,8a-dihydro-5h-naphthalen-4a-yl]acetate

C29H40O4 (452.2926)

(1s,4s,6r,7s)-7-[(1e)-2-[(1r,6s,7s,8s)-8-[(1r,2e)-1-hydroxy-2-methylbut-2-en-1-yl]-2,4,6,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]prop-1-en-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H40O4 (452.2926)

(6bs,8ar,9s,11r,12as,12bs,14ar)-3,9,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O5 (452.2563)

(1s,2r,7s,9r,11s,12s,15r,16s)-2,16-dimethyl-15-[(1r,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one

C28H36O5 (452.2563)

(6r)-6-[(1s)-1-[(1r,3as,3bs,9as,9bs,11as)-9a,9b,11a-trimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C29H40O4 (452.2926)

1-acetyl-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl benzoate

C28H36O5 (452.2563)

[5-(furan-3-yl)-2-[2-(1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl)ethyl]pentyl]oxysulfonic acid

C25H40O5S (452.2596)

7-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C28H36O5 (452.2563)

1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

(6bs,8ar,9s,11s,12as,12bs,14ar)-3,9,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O5 (452.2563)

(1r,3ar,3br,4r,5as,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-3,7-dioxo-1h,2h,3ah,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

8-{11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

[(4ar,4bs,6ar,6bs,7r,11ar,13ar)-1,1,4a,6a,7,11a-hexamethyl-2,9-dioxo-3h,4h,4bh,5h,6h,6bh,7h,8h,11h,13h,13ah-indeno[2,1-a]phenanthren-10-yl]acetic acid

C29H40O4 (452.2926)

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C29H40O4 (452.2926)

[(2s)-2-{2-[(1r,2r,4as)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl]oxysulfonic acid

C25H40O5S (452.2596)

(4s,4ar,5s,7r,8r,8as)-2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-[(2r)-undecan-2-yl]-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C26H44O6 (452.3138)

(1r,5s,8r)-8-[(1r,3as,3bs,9ar,9bs,11r,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

7-{2-[8-(1-hydroxy-2-methylbut-2-en-1-yl)-2,4,6,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]prop-1-en-1-yl}-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H40O4 (452.2926)

(9r)-2,16-dimethyl-15-[(1r,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxatetracyclo[9.7.0.0³,⁹.0¹²,¹⁶]octadeca-2,4-dien-7-one

C28H36O5 (452.2563)

(1r)-1-{[(2s,3e,12bs)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]methyl}-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol

C29H32N4O (452.2576)

(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one

C28H36O5 (452.2563)

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)

(1r,5r,8r)-8-[(11r)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

[1-(2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-6-(furan-3-yl)-3-methylhexan-2-yl]oxysulfonic acid

C25H40O5S (452.2596)

(1r,4s,5r,5ar,9ar,9br,11as)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

15-(furan-3-yl)-2,7,7,11,16-pentamethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadeca-3,12-dien-10-yl acetate

C28H36O5 (452.2563)

[(1r,2s,4as,10br,12as)-8-hydroxy-2,4a,7,10b,12a-pentamethyl-9-oxo-1-(2-oxopropyl)-3,4,11,12-tetrahydro-1h-chrysen-2-yl]acetic acid

C28H36O5 (452.2563)

7,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C28H36O5 (452.2563)

(2r,4s,4ar,6as,12bs,14as,14bs)-4,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,8,13,14,14b-octahydropicene-3,6-dione

C28H36O5 (452.2563)

(1r,3r,3as,3bs,5s,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e)-6-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C26H44O6 (452.3138)

(6r)-6-{1-[(1z,2s,3as,3bs,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-ylidene]ethyl}-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

6-(1-{9a,9b,11a-trimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C29H40O4 (452.2926)

10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid

C28H36O5 (452.2563)

[(5e)-2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]oct-5-en-1-yl]oxysulfonic acid

C25H40O5S (452.2596)

2,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-4,5,6,13,14,14b-hexahydro-1h-picene-3,8-dione

C28H36O5 (452.2563)

(2e)-n-{3-[(2r,5r)-5-(3-{[(2e)-1,5-dihydroxy-3-methylpent-2-en-1-ylidene]amino}propyl)-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}-5-hydroxy-3-methylpent-2-enimidic acid

C22H36N4O6 (452.2635)

(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1s)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C29H40O4 (452.2926)

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11s,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

(1s,2s,4r,8r,9s,10z,12r)-12-hydroxy-8-isopropyl-1,5,11-trimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-5,10,13-trien-2-yl (2e)-3-(1-methylimidazol-4-yl)prop-2-enoate

C27H36N2O4 (452.2675)

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-3,4,5,6,8,13,14,14b-octahydro-1h-picene-2-carboxylic acid

C29H40O4 (452.2926)

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)

(1s,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2r,3r,6r)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C28H36O5 (452.2563)

(1r,3as,3br,9as,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid

C29H40O4 (452.2926)

[(2s,3r)-1-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-6-(furan-3-yl)-3-methylhexan-2-yl]oxysulfonic acid

C25H40O5S (452.2596)

1-({3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl}methyl)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol

C29H32N4O (452.2576)

(2r,3r,4s,4ar,6ar,6bs,14as,14br)-2,3-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,14,14a-decahydropicene-4-carboxylic acid

C29H40O4 (452.2926)

4-[(1r,2r)-2-{4-[(1e)-3,3-dimethylpenta-1,4-dien-1-yl]-2-methoxyphenoxy}-1-hydroxy-3,3-dimethylpent-4-en-1-yl]-2-methoxyphenol

C28H36O5 (452.2563)

(6r)-6-[(1s)-1-[(3as,3bs,6s,9ar,9bs,11as)-6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl (2r)-2-methylbutanoate

C26H44O6 (452.3138)

5-(2,5,8a-trimethyl-5-{[(3-phenylpropanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-enoic acid

C29H40O4 (452.2926)

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 2-methylbutanoate

C26H44O6 (452.3138)

(2s,3r,4s,5r,6r)-2-{[(1s,4as,7r,8as)-1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl (2s)-2-methylbutanoate

C26H44O6 (452.3138)

n-[3-(5-{3-[(1,5-dihydroxy-3-methylpent-2-en-1-ylidene)amino]propyl}-3,6-dihydroxy-2,5-dihydropyrazin-2-yl)propyl]-5-hydroxy-3-methylpent-2-enimidic acid

C22H36N4O6 (452.2635)

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)

1-(6-hydroxy-5-methylhex-3-en-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C26H44O6 (452.3138)

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)

[(5e)-2-[3-(furan-3-yl)propyl]-6-methyl-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-1-yl]oxysulfonic acid

C25H40O5S (452.2596)

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)

6-(1-{3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

(1r,3as,3br,9ar,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid

C29H40O4 (452.2926)

(1s,3bs,4r,5s,5as,9as,9bs,11ar)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

[(1s,4s,5r,9s,10s,13r)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

2,3-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,14,14a-decahydropicene-4-carboxylic acid

C29H40O4 (452.2926)

6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate

C28H36O5 (452.2563)

(2s,3r,4r,5r,6s)-2-{[(3r)-5-[(1s,4as,8as)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O6 (452.3138)

(1s,2r,6s,7r,9r,11s,12s,16s)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

C28H36O5 (452.2563)

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

C25H40O7 (452.2774)

{14-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl}methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-6-(furan-3-yl)-11-(methoxymethoxy)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

C28H36O5 (452.2563)

(1r,3r,3as,3bs,5s,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e,5r)-6-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C26H44O6 (452.3138)

(3r,6s,8r,12s,15s,17r)-5,8,14,17-tetrahydroxy-3,12-bis(2-methylpropyl)-1,4,10,13-tetraazatricyclo[13.3.0.0⁶,¹⁰]octadeca-4,13-diene-2,11-dione

C22H36N4O6 (452.2635)

(1r,2r,10r,11s,14r,15s,16r)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one

C28H36O5 (452.2563)

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11r,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

(10z)-12-hydroxy-8-isopropyl-1,5,11-trimethyl-15-oxatricyclo[10.2.1.0⁴,⁹]pentadeca-5,10,13-trien-2-yl (2e)-3-(1-methylimidazol-4-yl)prop-2-enoate

C27H36N2O4 (452.2675)

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

C25H40O7 (452.2774)

{2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1s,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]oct-5-en-1-yl}oxysulfonic acid

C25H40O5S (452.2596)

1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

n-{1-[(2r,5s,6r)-5-{[(4s,5s,6r)-5-(dimethylamino)-4-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-2-methylpropanamide

C22H36N4O6 (452.2635)

(1r)-1-{[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C27H36N2O4 (452.2675)

(2r,6r)-6-[(1r,5as,6s,9as,11ar)-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O4 (452.2926)

2,16-dimethyl-15-{1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl}-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadec-4-en-3-one

C28H36O5 (452.2563)

methyl (6bs,8as,11r,12ar,12bs,14ar)-6b,8a,11,12b,14a-pentamethyl-2,4-dioxo-7h,8h,9h,10h,12h,12ah,13h,14h-phenanthro[2,1-f]isochromene-11-carboxylate

C28H36O5 (452.2563)

(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one

C28H36O5 (452.2563)

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

C25H40O7 (452.2774)

(6s)-6-[(1r)-1-[(1s,6s,9ar,9bs,11as)-1,6-dihydroxy-9a,11a-dimethyl-9-oxo-2h,3h,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

(1s,4s,6r,7s)-7-[(1e)-2-[(1s,6r,7r,8r)-8-[(1r,2e)-1-hydroxy-2-methylbut-2-en-1-yl]-2,4,6,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]prop-1-en-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H40O4 (452.2926)

(1s,9r,11s,12s,15r,16s)-2,16-dimethyl-15-[(1r,4r,5r)-1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl]-8-oxatetracyclo[9.7.0.0³,⁹.0¹²,¹⁶]octadeca-2,4-dien-7-one

C28H36O5 (452.2563)

(2s,3r,4r,5r,6s)-2-{[(3r)-5-[(1s,4ar,6s,8ar)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol

C26H44O6 (452.3138)

(2r,4as,6as,12br,14as,14br)-2,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-4,5,6,13,14,14b-hexahydro-1h-picene-3,8-dione

C28H36O5 (452.2563)

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11s,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

[6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

(6bs,7s,8ar,9s,11r,12as,12bs,14as)-3,7,9-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O5 (452.2563)

(6bs,8ar,10s,11s,12as,12bs,14ar)-3,10,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,10,12,12a,13,14-hexahydro-7h-picene-2,9-dione

C28H36O5 (452.2563)

(2z,6e,10e)-6,10-dimethyl-12-(4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl acetate

C29H40O4 (452.2926)

(1r)-1-{[(2s,3r,11bs)-3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C27H36N2O4 (452.2675)

(1r,4s,6r,7r)-7-[(1e,3e,5e,7e,9e)-10-[(2r,3s,6s)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C28H36O5 (452.2563)

[(1s,4ar,5s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)

6-(1-{1,6-dihydroxy-9a,11a-dimethyl-9-oxo-2h,3h,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

3,7,9-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O5 (452.2563)

methyl 2-[2-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-5-(3-methylbut-2-en-1-yl)-1,4-dioxo-8,8a-dihydro-5h-naphthalen-4a-yl]acetate

C29H40O4 (452.2926)

(1s,7s)-7-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C28H36O5 (452.2563)

(1r,4r,5r,7s)-7-[(1r,3as,3bs,9ar,9bs,11as)-1-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-4,5-dimethyl-2-oxabicyclo[3.2.1]octan-3-one

C28H36O5 (452.2563)

(2s,5r,6r,10r,13r,14r)-2,5,10,14-tetramethyl-13-[(2s)-1-(4-methylfuran-2-yl)-1-oxopropan-2-yl]tetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-1(9)-ene-5-carboxylic acid

C29H40O4 (452.2926)

[8-hydroxy-2,4a,7,10b,12a-pentamethyl-9-oxo-1-(2-oxopropyl)-3,4,11,12-tetrahydro-1h-chrysen-2-yl]acetic acid

C28H36O5 (452.2563)

[(2s,5e)-2-[3-(furan-3-yl)propyl]-6-methyl-8-[(1s)-2,6,6-trimethylcyclohex-2-en-1-yl]oct-5-en-1-yl]oxysulfonic acid

C25H40O5S (452.2596)

7'-o-demethylisocephaeline

C27H36N2O4 (452.2675)

(6r)-6-[(1r)-1-[(1s,3ar,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

6,10-dimethyl-12-(4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl acetate

C29H40O4 (452.2926)

6-(1-{2-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-ylidene}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

7-[10-(3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C28H36O5 (452.2563)

(1r,4as,7as)-3-[(2e)-4-(2,5-dimethoxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-4a,5',5',7a-tetramethyl-6,7-dihydro-5h-spiro[cyclopenta[c]pyran-1,2'-furan]

C29H40O4 (452.2926)

6-{6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C29H40O4 (452.2926)

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

[(1s,4s,5r,9s,10r,13r,14r)-14-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

(1s,2r,6s,7r,9r,11r,15r,16r)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,12-dien-3-one

C28H36O5 (452.2563)

(1s,2r,4r,6s,7s,10r,11r,16r,18r)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-18-yl acetate

C28H36O5 (452.2563)

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11r,11as)-11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

(6r)-6-[(1r)-1-[(3ar,3br,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-9-oxo-3h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

(1r,2r,10r,11s,14r,15r,16r)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-15-hydroxy-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one

C28H36O5 (452.2563)

2-{[5-(6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol

C26H44O6 (452.3138)

(1s)-1-{[(2s,3e,12bs)-3-ethylidene-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]methyl}-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol

C29H32N4O (452.2576)

(2-{2-[(1r,2r,4as)-1,2,5,5-tetramethyl-2,3,4,4a,6,7-hexahydronaphthalen-1-yl]ethyl}-5-(furan-3-yl)pentyl)oxysulfonic acid

C25H40O5S (452.2596)

{2-[3-(furan-3-yl)propyl]-6-methyl-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-1-yl}oxysulfonic acid

C25H40O5S (452.2596)

1-({3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}methyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C27H36N2O4 (452.2675)

(2s,3r,4s,11's,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2',5',12'-triene-4',7'-dione

C28H36O5 (452.2563)

(1r,3br,4s,5r,5as,9ar,9br,11as)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

[14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

8-{5-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

(1's,2s,3r,4s,10'r,11'r,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2',5',12'-triene-4',7'-dione

C28H36O5 (452.2563)

(6r)-6-[(1r)-1-[(1s,3br,9ar,9bs,11ar)-9a,11a-dimethyl-9-oxo-1h,2h,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-hydroxyethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C28H36O5 (452.2563)

(1r,2s,5s,6r,7s,10r,11s,14s,15r,16s)-2,6,11,15-tetramethyl-5,14-dipropyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

C26H44O6 (452.3138)

(1s)-1-{[(2s,3r,11bs)-3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol

C27H36N2O4 (452.2675)

2,16-dimethyl-15-{1-methyl-8-methylidene-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-4-yl}-8-oxatetracyclo[9.7.0.0³,⁹.0¹²,¹⁶]octadeca-2,4-dien-7-one

C28H36O5 (452.2563)

(1r,3br,4s,5r,5ar,9ar,9br,11as)-1-(furan-3-yl)-5-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O5 (452.2563)

ethyl (2r,4r)-4-[(1r,3as,3br,4r,5as,7r,9as,9bs,11s,11ar)-4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxypentanoate

C26H44O6 (452.3138)

3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2',5',12'-triene-4',7'-dione

C28H36O5 (452.2563)

ethyl 2-hydroxy-4-{4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}pentanoate

C26H44O6 (452.3138)

3,9,11-trihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O5 (452.2563)

(1s,3as,3bs,7s,9ar,9bs,11r,11as)-1-acetyl-3a,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl benzoate

C28H36O5 (452.2563)

(2r,4as,6as,12bs,14as,14br)-7,10,11-trihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C28H36O5 (452.2563)

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-hydroxy-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-3-one

C28H36O5 (452.2563)

8-{11-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,8h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

8-{5a-hydroxy-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,5h,6h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O5 (452.2563)

(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one

C28H36O5 (452.2563)

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)

(1r,3br,4s,5r,5as,9ar,9br,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-5-yl acetate

C28H36O5 (452.2563)

4-hydroxy-7-{1-hydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-4,5-dimethyl-2-oxabicyclo[3.2.1]octan-3-one

C28H36O5 (452.2563)